Cost Effectiveness of Peginterferon α-2a Plus Ribavirin versus Interferon α-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C. The Authors’ Reply
- 41 Downloads
KeywordsMajor Public Health Concern Simulated Population Incremental Benefit Fibrosis Progression Male Cohort
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
© Adis Data Information BV 2004